Shiseido has agreed to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics, which produces and markets the Aupres beauty brand. The buyer is an investor consortium led by IDG Capital, according to the reports.
Both outlets frame the move as a restructuring step that separates Shiseido’s China operations tied to the Aupres label from its broader business. WWD describes the entity being sold in terms of its production role for Aupres, while Business of Fashion emphasizes that the subsidiary both manufactures and markets the brand. Neither source provides additional deal terms or timing details in the material provided, and the reports focus primarily on identifying the asset and the lead investor.
Overall, the coverage aligns on the core transaction: Shiseido selling its Aupres-related producer unit in China to an IDG Capital–led consortium.